Plus a regimen that is effective against possible coinfection with Chlamydia trachomatis, such as doxycycline 100 mg, administered orally twice daily for 7 days. In clinical trials, these recommended regimens cured more than 95% of anal and genital infections; any of the regimens may be used for uncomplicated anal and genital infection. Published studies indicate that ceftriaxone 125 mg and ciprofloxacin 500 mg can cure more than 90% of pharyngeal infections. If pharyngeal infection is a concern, one of these two regimens should be used.25 No ceftriaxone-resistant strains of Neisseria gonorrhoeae have been reported. The drawbacks of ceftriaxone are 1 ; it is expensive, 2 ; it is currently unavailable in vials smaller than 250 mg, and 3 ; it must be administered by injection. Some healthcare providers believe that the discomfort of the injection may be reduced by using 1% lidocaine as a diluent. Ceftriaxone also may abort incubating syphilis, a concern when gonorrhea treatment is not accompanied by a 7-day course of doxycycline or erythromycin for the presumptive treatment of chlamydia.25 Cefixim3 has an antimicrobial spectrum similar to that of ceftriaxone. Cfixime appears to be effective against pharyngeal gonococcal infection, but few patients with pharyngeal infection have been included in studies. No gonococcal strains resistant to cefixime have been reported. The advantage of cefixime is that it can be administered orally. Whether the 400-mg dose can cure incubating syphilis is not yet known.25 Ciprofloxacin, at a dose of 500 mg, provides sustained bactericidal levels in the blood. Ciprofloxacin can be administered orally and is less expensive than ceftriaxone. No resistance has been reported in the United States, but strains with decreased susceptibility to some quinolones are becoming common in Asia. Quinolones are contraindicated for pregnant or nursing women and for persons younger than 17 years of age, on the basis of information from studies with animals. Quinolones are not active against Treponema pallidum.25 Many other antimicrobials are active against Neisseria gonorrhoeae. These guidelines are not intended to be a comprehensive list of all effective treatment regimens. Follow-Up. Patients with uncomplicated gonorrhea who are treated with any of the regimens in these guidelines need not return for a test of cure.

Cefixime 200mg An insertion in the TK gene of isolate 1246 99 and a deletion of one nucleotide in isolate 496 02 yield a truncated altered thymidine kinase enzyme resulting in a TK negative phenotype and clinical resistance against acyclovir. The inhibitory activity of three different essential oils against herpes simplex virus isolates was tested in vitro on RC-37 cells using a plaque reduction assay. Results: All essential oils exhibited high levels of antiviral activity against acyclovir-sensitive HSV strain KOS and acyclovir-resistant HSV isolates 1246 99 and 496 02 as well as acyclovir-resistant strain Angelotti. At maximum noncytotoxic concentrations of the plant oils, plaque formation was significantly reduced by 96.6% to 99.9%. Only a modest or no significant effect on viral infectivity could be achieved by adding these compounds during the adsorption phase or replication phase, respectively. Conclusions: These results indicate that anise oil, dwarf-pine oil and camomile oil affected the virus before adsorption and in a different manner than acyclovir. Thus the investigated essential oils are capable to exert a direct effect on HSV and might be useful in treatment of drugresistant viruses. ISE.007 Staphylococcus aureus Resistance to Antibiotics S. Josifova, V. Stefanovska, V. Dzartovska, A. Bajrami. General Hospital Kumanovo, Kumanovo, Former Yugoslav Republic of Macedonia Background: To present S. Aureus resistance to the mostly administrated antibiotics with patients in our hospital. Methods: Microbiological analyses of corporeal secreta and excreta, blood and smear taken from a patient`s body have been done. Disc diffusion method i.e agar plate, has been used for antibiograms. Results: Out of 532 isolates of S. aureus, 31.2% originates from lesion or skin; 33.3% from nose; 15.2% -throat; 10.4% urogenital tract and urinoculture; 5.6%-ear and eye; and 4.3%-chemoculture. Following these antibiograms it can be noticed that 88.5% of the S. aureus isolates are resistant to Penicillin; 9.1% are with mild sensitivity and 2.4% only are sensitive. This is due to the S. aureus ability to production of beta lactamasis. Something similar happens to Ampicillin with resistance of 79.5%. Resistance to cephalosporins Cefalexin, Ceftriaxon, Ceflxime ; is significantly lower and counts 17.3%. The same refers to macrolide antibiotics Erythromycin, Claritromycin and Azitromycin ; as well, with resistance at 16.1%. 1 3 of the S. Aureus are resistant to Gentamicin and Cotrimoxasol, where more than a half 54.1% ; are resistant to tetracyclines. Chloramphenicol has beneficial in vitro effect with 63.9%. The lowest percent i.e. 8.2% of the resistant types is to Klindamycin and 7.4% to Neomycin. Urethral smear and urinoculture isolates have been used in order to analyse the resistance of S. aureus to fluorokinolonies where a low percent of resistance has been noted. Conclusion: Occurance of a number of multi-resistant types of S. aureus keeps limiting the already existing treating options to these infections. Beta-lactamasis resistant antibiotics are still of great importance in treating them. As far as for severe, vitally endangering infections, combinations of two or more antibiotics have been used. ISE.008 Hospital Consumption of Antibiotics in Slovenia in 2006 M. Cizman, Slovenian Surveillance Antibiotics Consumption Study Group. University Medical Center, Ljubljana, Slovenia Background: To collect data on hospital use of antibiotics in Slovenia at national level. Methods: Consumption data of systemic antibiotics in Anatomic Therapeutic Chemical ATC ; class J01 were collected from all hospitals and expressed in defined daily doses DDD ; per 100 bed-days HBD ; , per 100 admissions HA ; and per 1000 inhabitants per day TID ; . Results: In 2006 Slovenia 2008516 inhabitants ; had 361912 inpatients, 2571676 bed-days and average length of stay in 29 hospitals was 7.1 days. In 2006 the national hospital antibiotic consumption was 49.51 DDD HBD, 325.26 DDD HA and 1.70 DDD TID respectively. In one teaching hospital the consumption was 63.04 DDD HBD and in 11 general hospitals the mean consumption was 57.54 46.7969.22 ; DDD HBD respectively. Penicillins 36.8 % ; , cephalosporins 20.4 % ; , quinolones 16.7 % ; macrolides and lincosamides 9, 6% ; and aminoglycosides 4, 78% ; were five most commonly used classes of antibiotics. Conclusion: Hospital consumption of antibiotics in Slovenia is moderate. The data provide the basis for further surveillance and interventions. Cefixime vs augmentin A retired general and vascular surgeon in private practice, he had been affiliated with Mountainside and Montclair Community hospitals in Montclair, N.J., before moving to Colorado. He is survived by his wife, Kathleen, and four sons. CNS: post-op pain, infxn, abscess, tumor, CVA, DT's, trauma, Guillain-Barre, subdural - neoplastic: bronchogenic, mesothelioma, pancreatic, sarcoma, bladder, prostate, GI, lymphoma - drugs: chlorpropamide, dDAVP, oxytocin, psychotropics, carbamazepime, TCA's, opiates, vincristine, cytoxan, colchicine, NSAIDs 5. Reset osmostat rare ; Treatment: Hypovolemic: replete volume with NS until hemodynamically stable. Then calculate sodium deficit and replace half of that deficit with NS 154 mEq Na L ; over the first 12-24 hours max 1-2 mEq hr, if asymptomatic 0.5 mEq hr ; . Na deficit mEq ; pt mass kg ; * 0.6 L kg for men, 0.5 L kg for women ; * 140-Na ; 140 Hypervolemic euvolemic: fluid restrict to 1.0-1.5L 24hr. If symptomatic Sz, AMS ; , replace with 3% NaCl 513mEq L ; at 1-2 mEq L hr until Na 120 or Sx resolve: 3% NaCl gtt rate ml hr ; pt mass kg ; * 0.6 or 0.5 L kg ; * 1 mEq L hr.

Cefixime tellurite supplement 4867 Separation of macroscopic, elastic mismatch and thermal expansion mis t stresses in metal matrix composite quenched plates from neutron di raction measurements 4877 Microstructural change in austenitic initiated by spinodal decomposition and its in uence on mechanical properties 4887 The solidi cation characteristics of 6061 and a356 aluminum alloys and their ceramic particle-reinforced composites 4901 Microstructural stability and creep rupture strength of the martensitic steel p92 for advanced power plant 4909 Fine tuning at sigma-3n boundaries in nickel 4917 In-situ high temperature x-ray di raction study of ni al2o3 interface reactions 4923 Microstructures and deformation behaviour in nb 10-25at-percent-al 20-40atpercent-v alloys 4939 Deformation mechanics in a mechanically alloyed fe-40al alloy and the in uence of recrystallizing and ageing heat treatments 4953 A nite element method for simulating interface motion .2. large shape change due to surface di usion 4963 Chemical potential shifts due to capillarity unary systems 4969 Interface e ects on crack de ection and bridging during fatigue crack growth of titanium matrix composites 4981 Solidi cation microstructure maps in ni-al alloys 4993 Atomistic simulation of dislocation nucleation and motion from a crack tip 5005 On velocity and spacing selection in discontinuous precipitation .1. simpli ed analytical approach 5015 Spray forming and co-injection of particulate reinforced tial tib2 composites 5031 A uni ed theory of recovery, recrystallization and grain growth, based on the stability and growth of cellular microstructures .2. the e ect of second-phase particles. For gonorrhea diagnosis is a major challenge to monitoring antimicrobial resistance in N. gonorrhoeae. The changes in antimicrobial resistance patterns described in this report were identified only because culture was used as the diagnostic testing method in these sites and because susceptibilities were being measured through GISP for Kansas City. HSL is one of the few state public health laboratories performing antimicrobial susceptibility testing on all gonococcal isolates identified by culture. Clinicians who suspect or identify a N. gonorrhoeae infection treatment failure should submit a gonococcal culture specimen to the local health laboratory for susceptibility testing. CDC requests reports of treatment failures or resistant gonococcal isolates from clinicians or laboratories National Center for HIV, STD and TB Prevention, Division of STD Prevention, telephone [404] 639-8373 ; . CDC recommends that local health laboratories with the capacity to perform antimicrobial susceptibility testing on N. gonorrhoeae isolates routinely test for susceptibility to antimicrobials used locally for gonorrhea treatment e.g., a fluoroquinolone, cefixime or ceftriaxone, azithromycin, and spectinomycin ; . Gonococcal isolates resistant to these classes of antimicrobials can be forwarded to CDC's Neisseria Reference Laboratory telephone [404] 6392134 ; for confirmation and further evaluation and flagyl. 15mg kg twice a day suggests that pneumococcal MICs of 4 g ml or greater may be required before clinical failures occur. The most recent NCCLS guidelines categorize isolates of pneumococci with a cefuroxime MIC of 4 g ml or greater as resistant 233 ; . Using breakpoints, which were the same as those in the new NCCLS guidelines, Doern et al 216 ; found that of the 41% of pneumococci that were PNSP, in a 1997 North American antimicrobial resistance surveillance program, 61% and 41% were resistant to cefixime and cepodoxime, respectively. As the prevalence of PNSP continues to increase, we may see an increase in the number of clinical failures associated with oral cephalosporin therapy of pneumococcal respiratory tract infections. Antimicrobial inactivation -lactamase destroys penicillins and cephalosporins by hydrolysis and is the single greatest cause of resistance to these antimicrobials. -lactamases account for greater than 99% of -lactam resistance in H influenzae and M catarrhalis 224, 234 ; . Among the various -lactamase enzymes, the TEM-1 and TEM-2 enzymes, which hydrolyze ampicillin and amoxicillin, are the enzymes most commonly seen in H influenzae 235 ; . M catarrhalis produces ROB-1 and ROB-2 enzymes, which also hydrolyze ampicillin and amoxicillin, but have no effect on cephalosporins 236 ; . Studies done in the late 1990s have found rates of -lactamase positivity in H influenzae between 30% and 40% in North America and about 20% in Europe 224, 225, 237-239 ; . -lactamase resistance in M catarrhalis rose very rapidly to over 90% in most countries of the world and has remained stable at that rate 224, 225, 237-239 ; . Although there are no NCCLS breakpoints for M catarrhalis, the degree of activity of all the antimicrobials used to treat AECB, with the exception of amoxicillin, have excellent activity against this pathogen 239.

Trimethoprim-sulfamethoxazole TMP-SMX ; for upper or lower respiratory tract pathogens, with the exception of Streptococcus pyogenes, which can cause pharyngitis or tonsillitis. Penicillin remains the drug of choice for pharyngitis, except in cases in which a high risk of noncompliance can be anticipated, in which case a macrolide with shorter duration of therapy should be considered. Skin and skin structure infections generally respond well to a first-generation cephalosporin or a penicillinase-resistant penicillin such as dicloxacillin. Cefuroxime axetil has been shown to be as effective as doxycycline in early Lyme disease.28 The "third-generation" cephalosporins include cefixime and cefpodoxime proxetil.29, 30 These antibiotics are characterized by an extended spectrum against gram-negative organisms such as E. coli and Klebsiella; nosocomial bacteria such as Pseudomonas aeruginosa, Enterobacter, Serratia, and others are generally resistant to these agents. Cefpodoxime proxetil has moderate gram-positive activity, while that of cefixime is poor and chloramphenicol. Patients. The majority of the remainder of patients with an AUIC 125 were clinical failures and showed stepwise increases in MIC, indicating that they were becoming resistant to treatment. AUIC values between 125 and 250 resulted in the same bacterial endpoint as those with values 250, but eradication was much slower; 6 days for 50% killing with an AUIC 125250 compared with 1 day with AUIC 250. In acutely ill patients with nosocomial lower respiratory tract infections, of patients treated with an antimicrobial with an AUIC 100, about 40% showed stepwise increases in MIC by day 4, and by day 20 about 80% showed reduced susceptibility, whereas with an AUIC 100, only 8% of pathogens developed resistance by 20 days after initiation of therapy Figure 3 ; .40 There is less likelihood of resistance emerging if the concentration of antimicrobial adequately exceeds the MIC for a particular pathogen. Table IV. Percentage susceptibility %s ; for rufloxacin and other drugs against respiratory pathogens Strain M. catarrhalis Antibiotic rufloxacin amoxycilhn co-amoxiclav cefixime ciprofloxacin clarithromycin rufloxacin amoxycillin co-amoxiclav cefixime ciprofloxacin clarithromycin rufloxacin co-amoxiclav cefixime ciprofloxacin rufloxacin amoxycillin co-amoxiclav ciprofloxacin clarithromycin rufloxacin amoxycillin co-amoxiclav cefixime ciprofloxacin clarithromycin F 27 ; 92.5 11.1 100 ; 100 68 98 ; 63.6 90.9 63.6 ; 47.3 15.7 63.1 ; 0 100 D 50 ; 100 16 100 ; 100 80 90.6 ; 93.3 66.6 100 ; 90 43.3 93.3 ; 6.8 100 I 30 ; 100 13.3 100 ; 100 82.6 100 ; 100 ; 80 10 17.5 E 32 ; 100 37.5 100 ; 100 55.7 98 ; 80 100 ; 61.5 7.6 65.3 ; 2.3 100 UK 39 ; 97.4 43.5 100 ; 94.6 70.6 98.6 ; 93.3 86.6 100 ; 83.3 30 100 ; 1.8 100 and bactrim. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 80: 2012-2020. 7. Biffl, W. L., E. E. Moore, F. A. Moore, and C. C. Barnett, Jr. 1995. Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. Leukoc. Biol. 58: 582-584. 8. Kettritz, R., M. L. Gaido, H. Haller, F. C. Luft, C. J. Jennette, and R. J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int. 53: 84-91. 9. Daffern, P. J., M. A. Jagels, and T. E. Hugli. 1999. Multiple epithelial cell-derived factors enhance neutrophil survival. Regulation by glucocorticoids and tumor necrosis factor-alpha. Am. J. Respir. Cell Mol. Biol. 21: 259-267. 10. Wislez, M., J. Fleury-Feith, N. Rabbe, J. Moreau, D. Cesari, B. Milleron, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel. 2001. granulocyte-macrophage colony-stimulating factor and Tumor-derived granulocyte J. Fecal culture for Escherichia coli O157: H7 was compared to rectoanal mucosal swab RAMS ; culture in dairy heifers over a 1-year period. RAMS enrichment culture was as sensitive as fecal culture using immunomagnetic separation IMS ; P 0.98, as determined by a chi-square test ; . RAMS culture is less costly than fecal IMS culture and can yield quantitative data. Domestic ruminants are the primary reservoir for Escherichia coli O157: H7, and the on-farm ecology of this organism has been studied extensively 2, 4, 11, ; . Environmental reservoirs likely play an important role 6, 10, 12, ; , but individual animals may also contribute significantly to the maintenance and spread of E. coli O157: H7 on the farm. The duration of carriage varies widely between individual animals. Most animals excrete culture-positive feces for less than 1 week, but there are a few animals that are feces positive for several weeks or even months 2, 3, 5, ; . Recent findings 15, 19 ; that the rectoanal-junction mucosa is a major colonization site for E. coli O157: H7 in the bovine intestine also suggest that host colonization factors may play an important role. Rectoanal mucosal swab RAMS ; culture has been shown to be more sensitive than fecal culture for dairy 21 ; and feedlot 9 ; cattle. Immunomagnetic separation IMS ; 23 ; of E. coli O157 from fecal samples after enrichment culture is often used to increase the sensitivity of fecal culture, but this technique is expensive and does not provide quantitative information in the form of bacterial counts sample. We hypothesized that RAMS culture is at least as sensitive as fecal IMS with enrichment culture and that, as suggested by Rice et al. 21 ; , RAMS culture could be used to detect carrier animals. To compare the sensitivity of RAMS culture to the sensitivity of fecal culture and to evaluate the ability of RAMS culture to predict the duration of carriage, we conducted a longitudinal study of the natural E. coli O157: H7 status among dairy heifers in which we sampled individual heifers over time at monthly intervals for 12 months, using i ; direct and enriched RAMS culture, ii ; direct fecal culture, and iii ; fecal IMS. Two university dairy herds were used. Dairy A had a closed herd and raised calves on its premises. Dairy B raised calves on its premises but sent heifers to be raised at another facility until they were 12 to 14 months old, so the dairy B heifers were at the heifer-raising facility for the duration of the study. Hutch calves were fed milk replacer at dairy A and waste milk at dairy B, and after weaning at both dairies the animals were fed a pelleted grain calf starter prepared at a local feed mill. The calf starter consisted of barley, corn, oats, soybean meal, vitamins, minerals, and a coccidiostat. After weaning, calves were placed in group pens containing three to five animals per pen, and after several weeks they moved to pens with larger numbers of heifers per pen. At the initial visit to each dairy, a cohort of 20 heifers that were 2 to 6 months old was identified. At each subsequent monthly visit, newly weaned heifers were added to the study until each herd contained 40 animals. Heifers were sampled once each month for 12 months, and there was not more than a 15-day variation in the interval. Each animal that yielded a positive sample at the monthly visit was resampled 5 to 9 days later. At each visit, two samples were collected from each animal: freshly passed feces and a rectoanal mucosal swab. The order of sample collection was always i ; free-catch feces if available ; , ii ; RAMS, and then iii ; feces collected by rectal palpation if free catch was not available. RAMS samples were collected and processed as previously described 21 ; . Briefly, a sterile foam-tipped applicator catalog no. 10812-022; VWR International, Buffalo Grove, IL ; was inserted approximately 2 to 5 into the anus, and the circumference of the rectoanaljunction mucosa was swabbed 21 ; . Each swab was placed immediately into a culture tube containing 3 ml ice-cold Trypticase soy broth TSB ; Difco Laboratories, Detroit MI ; . Fecal samples 15 g ; were placed immediately into sterile WhirlPak bags Nasco, Fort Atkinson, WI ; . All samples were kept on ice to prevent bacterial replication until laboratory processing within 6 h after collection. Swabs in cold TSB were vortexed for 1 min, and 10-fold serial dilutions in a sterile saline solution were spread plated onto individual sorbitol MacConkey agar plates SMac ; Difco Laboratories, Detroit, MI ; containing cefixime 50 ng ml; Wyeth-Ayerst, Pearl River NY ; , potassium tellurite 2.5 g ml; Sigma Chemical Co., St. Louis MO ; , vancomycin 40 g ml and cefadroxil.
201. Ziccardi, M., Rogers, W.J., Schecter, A.J., Ppke, O. and Denison, M.S. 1997. Direct detection of dioxins and related chemicals in small quantities of human serum using a recombinant cell bioassay. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 31: 215-218. 202. Schecter, A., Ppke, O., Isaac, J., Hrimat, N., Neiroukh, F., Safi, J. and El-Nahhal, Y. "2, 3, 7, 8 Chlorine substituted dioxin and dibenzofuran congeners in 2, 4-D, 2, and pentachlorophenol. 1997. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 32: 51-55. 203. Ryan, J.J., Schecter, A.J. and Amirova, Z. 1997. Russian phenoxy herbicide production workers: Exposure to and elimination of dioxins. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 33: 390-393. 204. Schecter, A., Ppke, O., Ryan, J.J., Frst, P., Isaac, J., Hrimat, N., Neiroukh, F., Safi, J., ElNahhal, Y., El Haj, S.A., Avni, A., Richter, E., Chuwers, P. and Fischbein, A. 1997. Dioxins, dibenzofurans, and PCBs in human blood, human milk, and food from Israel, the West Bank, and Gaza. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 33: 457-461. 205. Schecter, A., Ppke, O. and Dellarco, M. 1997. Dioxin, dibenzofuran, and PCB congeners in cooked and uncooked food. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 33: 462-466. 206. Schecter, A., Ryan, J.J. and Ppke, O. 1997. Dioxin and dibenzofuran levels in blood and adipose tissue following occupational exposures to pentachlorophenol. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 33: 467-472. 207. Schecter, A., Ppke, O., Frst, P. and Ryan, J.J. 1997. Temporal changes in dioxin and dibenzofuran levels in general population human blood and milk from Germany and the United States. Peer reviewed ; Short Papers from Dioxin `97, Indianapolis, Indiana, USA. Organohalogen Compounds 32: 473-478. 208. Schecter, A.J. 1998. A selective historical review of congener-specific human tissue measurements as sensitive and specific biomarkers of exposure to dioxins and related compounds. Environmental Health Perspectives 106 Suppl 2: 737-742. 209. Schecter, A.J., Dellarco, M., Ppke, O., and Olson, J. 1998. A comparison of dioxins, dibenzofurans and coplanar PCBs in uncooked and broiled ground beef, catfish, and bacon. Chemosphere 37: 723-1730. 210. Schecter, A.J., Kassis, I., and Ppke, O. 1998. Partitioning of dioxins, dibenzofurans, and coplanar PCBs in blood, milk, adipose tissue, placenta and cord blood from five American women. Chemosphere 37: 1817-1823. 211. Schecter, A.J., Ryan, J.J., and Ppke, O. 1998. Decrease in levels and body burden of dioxins, dibenzofurans, PCBs, DDE, and HCB in blood and milk in a mother nursing twins over a thirtyeight month period. Chemosphere 37: 1807-1816. 212. Lucier, G. and Schecter, A.J. 1998. Human Exposure assessment and the National Toxicology Program. Environmental Health Perspectives 106: 623-627. 213. Masuda, Y., Schecter, A.J., and Ppke, O. 1998. Concentrations of PCBs, PCDFs, and PCDDs in the blood of Yusho patients and their toxic equivalent contribution. Chemosphere 37: 1773-1780. 214. Smith, S., Schecter, A.J., Ppke, O., Do, T., Coulibaly, D. and Brandt-Rauf, P. 1998. Quantitation of the extracellular domain of epidermal growth factor receptor in the plasma of dioxin-exposed individuals. American Journal of Industrial Medicine 34: 1-5.

Feed samples were collected weekly and composited every 3 wk for analysis. Goats were weighed on two consecutive days a t 14-d intervals during the lactation trial and at the beginning and the end of the collection phase of the metabolism trial. Milk production was measured with a computerized flow metering device Westfalia Systemat, Elk Grove, IL ; . Composites of milk collected a t consecutive morning and afternoon milkings during wk 5, 10, and 15 of lactation were prepared. Ruminal samples, obtained via stomach tube, and blood samples, obtained via jugular venipuncture, were procured 4 h postprandially during wk 5, 10, and 15 of lactation. The first 20 to 30 ml of ruminal fluid was discarded to reduce salivary contamination. Thereafter, 2 50 ml was collected for analysis. Ruminal fluid pH was determined using a pH meter SA-720, Orion Research, Boston, MA ; immediately after sampling. Then, 1 ml of saturated HgCl2 solution was added to inhibit microbial fermentation. Twenty-milliliter subsamples of ruminal fluid was mixed with 1 ml of 2 M zinc acetate to preserve them for total sulfide-S including HzS-S, HS--S, and S2--S ; analysis Fresenius et al., 1988 ; . Ruminal nonionized, volatile sulfide3 H2S-S ; was calculated according to the Henderson-Hasselbalch equation Boyer, 1986 ; . The formula used was as follows: H 2 S - suUide-S * antilog 18.74 pHIA1 + antilog 6.74 - pHl1, where 6.74 is the PKa of sulfide4 H2S + HS- + H + , Ka 1.8 * 10-7; Bray and Till, 1975 ; . The H2S-S was a n estimate of the amount of sulfide-S that could volatilize and be lost through eructation and ceftin. Nal cancer in daughters of DES users, although rare, is significantly more common than among nonexposed women, and exposed women are known to have a higher proportion of reproductive tract anomalies resulting in infertility 117 ; $ Reports suggest that males exposed to DES commonly have abnormal spermatozoa and potentially diminished fertility 156 ; . The effects of physical agents on fertility are outlined in table 4-2. Certain medications and substances used for self-intoxication can also interfere with fertility. Most prominent among these agents are cigarette smoking discussed in next section ; and chronic and acute alcohol consumption. Chronic alcohol abuse is consistently associated with abnormalities of spermatogenesis and presumed subfecun dity in males. Although alcohol consumption impairs fertility in laboratory animals through a. 389 June 2006 Broader Community Prevention Strategies Universal interventions are targeted at communities or larger aggregations and may include environmental prevention strategies that focus on physical changes that reduce risk. In suicide prevention, barriers on high-altitude locations; modifications to automobile exhaust systems; and reducing access to lethal means, especially firearms, are examples of environmental strategies. Suicide attempts using highly lethal means, such as firearms, result in higher rates of death. Where the method is common, restrictions of means have led to lower overall suicide rates eg, firearms in Canada and in Washington, DC, and prescription and sale of medications in Australia ; . Restrictions on access to alcohol have coincided with decreases in overall suicide rates in several foreign countries. A survey in 1998 of 10, 000 U.S. students found that 4.3% reported having a working firearm at school, and those students engaged in behaviors that put themselves and others at risk for injury. Whether or not gun control legislation is possible, minimally, schools need consistent policies that are enforced about gun possession on campus. Another strategy might be to have guidelines for removal of access to firearms and other highly lethal items for high-risk students. Many campuses and neighboring communities have tall buildings or other high places that provide a means of self-harm. Restricting access to bridges, windows, and roofs, and access to poisons eg, cyanide in laboratories ; may be effective prevention strategies. Leadership by top administrators is key to generating significant and sustainable efforts on and off campus to change the environment to reduce factors that enhance alcohol and other drug misuse, depression, and suicide. Models of leadership initiatives include the Presidents Leadership Group of the Center for College Health and Safety, which involved activities supporting statewide initiatives, working on state-level funding for college alcohol and other drug prevention, and supporting local and regional alcohol and other drug prevention efforts. The AMA-based A Matter of Degree program developed campus community coalitions to change environmental policies that foster high-risk drinking. The interim evaluation of coalitions from 1999-2001 found that when colleges and communities focus their prevention efforts on key environmental influences, they can produce measurable declines in alcohol consumption and harm among both drinkers and those around them. A similar effort to engage campus administrative leaders on promotion of mental health and suicide prevention programs would facilitate enhanced efforts throughout higher education. RECOMMENDATIONS FOR APPROPRIATE SERVICES TO PSYCHIATRIC, ADDICTION MEDICINE, AND OTHER MENTAL HEALTH AND SUBSTANCE ABUSE SERVICES ON COLLEGE CAMPUSES In the context of the increased need to address student self-inflicted injury and in light of trends in legal decisions on liability for student deaths from alcohol and suicide, institutions must make efforts to adopt best practice prevention programs and procedures. A comprehensive approach would engage key players in the college community in a planning process that focuses on assessment, design, implementation, and evaluation of suicide prevention, and mental health and substance abuse activities. At the institutional level, top administrators need to consider mental health needs a priority. Philosophically, institutions must foster a culture such that student mental and physical health are an important and legitimate concern and responsibility of administrators, faculty, and staff. However, there are only a few examples from alcohol and suicide interventions to serve as models for policy. Each campus should review policies and protocols used by other institutions or that have been successful in other settings and may be adapted for use by colleges locally. Colleges should evaluate a variety of strategies, understand and address potential risks, and involve a cross-section of the campus and community to address student safety and well-being--approaches that are adaptable to multiple issues not limited to suicide or substance use. A comprehensive approach to mental health and prevention of suicide and substance-related problems on college and university campuses is needed. It should employ multiple strategies targeted at both the general campus population and identifiable at-risk populations as suggested by the 1999 Surgeon General's report. Such a comprehensive approach will be more effective when it includes consistent and coordinated activities in all the social spheres in which college students live, study, work, and play. Areas of change that may reduce problems of depression, suicide, and substance abuse include the following: Science and Public Health - 8 and amoxil. Parenteral Therapy Subcommittee The following IV monographs have been updated: dacarbazine, lidocaine, and vancomycin. There are new IV monographs for mycophenolate and porfimer see Formulary Additions on Page 1 ; . Topical Corticosteroids -- Therapeutic Interchange Addition A therapeutic interchange for topical corticosteroids has been created for acute and residential care. Weakly potent, potent or moderately potent, and very potent topical corticosteroids will be automatically substituted to hydrocortisone 1%, betamethasone 0.1%, and clobetasol propionate 0.05% respectively. Please see Page 3 and the insert for full details. Ticarcillin to Piperacillin -- Therapeutic Interchange Deletion Ticarcillin was removed from formulary in 1995; piperacillin was removed in February 2004. As orders for piperacillin are now subbed to piperacillin-tazobactam TAZOCIN ; , the ticarcillin to piperacillin interchange should be deleted. Etomidate AMIDATE ; injection -- Restriction Amendment Etomidate is now available as a special access drug to intensivists and members of the Department of Emergency Medicine for VIHA South Island ; as an alternative sedative hypnotic agent in rapid sequence intubation. Therefore, members of the Department of Emergency Medicine at the Saanich Peninsula Hospital are now included. Cefiximee SUPRAX ; oral -- Restriction Amendment Cefixume had been restricted to sexual assault protocol only. Based on revised Canadian Sexually Transmitted Disease STD ; Guidelines, it is now restricted to the treatment of uncomplicated cervical urethral rectal gonorrhea due to N. gonorrhoeae. Rifampin RIFADIN ; oral -- Restriction Deletion In 1989, rifampin was restricted for the treatment of tubersulosis, prophylaxis of meningococcal meningitis, and prophylaxis of Hemophilus meningititis. All prescribing restrictions have now been removed. Ezetimibe EZETROL ; oral -- Restriction Review Ezetimibe will remain on formulary resticted to Residential and Continuing Care facilities. P&T Committee Terms of Reference -- Policy and Procedure A.03 The requirement for a signed Conflict of Interest Form by P&T Committee members has been added to this policy. Patient's Own Medication -- Policy and Procedure C.09 The change includes the removal of wording regarding an Appendix which lists drugs that have been rejected by MAC and would never be considered to be used as Patient's Own Medication. This Appendix is outdated and has no current relevance, as this situation is covered with other policies and procedures!

Addiction to nicotine in tobacco is the major reason why people continue to smoke.2 People who are dependent on nicotine usually: smoke their first cigarette within 30 minutes of waking up3 smoke more than 15 cigarettes per day3 suffer from withdrawal symptoms within 24 hours of stopping smoking, such as cravings, irritability, anxiety, depression, restlessness, hunger, poor concentration and sleep disturbances. 2, 3 Cravings the urge or desire to smoke ; can be due to nicotine withdrawal. However, you may also have an urge or desire to smoke when you are in situations where you are used to smoking. Certain things may trigger cravings, such as: 4 places where you normally smoke, such as home, work, or the pub people who you usually smoke with, such as family or friends; or being alone habits or routines where you are used to smoking, such as when drinking coffee or alcohol, talking on the telephone, after meals, or when you want to relax emotions, such as anger, boredom, being tense or upset; or for some people, when they are happy. Other strategies to control STI in pregnancy Other strategies to reduce the impact of STI in pregnancy have included vaginal washing with chlorhexidine to reduce MTCT of HIV in Nairobi.102 This showed no overall reduction in intrapartum MTCT of HIV. There have been several studies of presumptive antibiotic treatment in pregnancy. A Kenyan trial of a single presumptive dose of cefetamet-pivoxil versus placebo in women with a previous history of LBW or stillbirth found lower rates of LBW, gonorrhoea at delivery, and postpartum endometritis in women who received the antibiotic.103 A larger randomised mass treatment trial of a single cycle of presumptive treatment azithromycin 1 g, cefixime 400 mg, and metronidazole 2 g ; in Rakai, Uganda, resulted in significant reductions in maternal cervical and vaginal infections and infant ON.104 The rates of early neonatal mortality and LBW were also significantly reduced.5 In neonates, the WHO recommends that all cases of conjunctivitis in the newborn should be treated for both N gonorrhoeae and C trachomatis. The recommended treatment regimen for gonococcal conjunctivitis is ceftriaxone 50 mg kg by intramuscular injection as a single dose to a maximum of 125 mg or alternatively kanamycin 25 mg kg as a single dose and cephalexin.
Boswell JB, Nienhuys TG. Reflectometric screening for otitis media: inconsistencies in a sample of Australian aboriginal children. Int J Pediatr Otorhinolaryngol. 1993; 25: 49-60. Boswell J, Nienhuys T, Rickards F, Mathews J. Onset of otitis media in Australian Aboriginal infants in a prospective study from birth. Australian Journal of Otolaryngology. 1993; 1: 232-237. Boswell JB, Nienhuys TG. Onset of otitis media in the first eight weeks of life in aboriginal and nonaboriginal Australian infants. Ann Otol Rhinol Laryngol. 1995; 104: 542-549. Boswell J. Auditory brainstem response and conductive hearing loss in infants. Australian Journal of Audiology. 1995; 17: 101-106. Boswell JB, Nienhuys TG. Patterns of persistent otitis media in the first year of life in aboriginal and non-aboriginal infants. Ann Otol Rhinol Laryngol. 1996; 105: 893-900. Boswell J. Presentation of early otitis media in 'Top End' Aboriginal infants. Aust N Z J Public Health. 1997; 21: 100-102. Bottaro G, Rotolo N, Bonforte S, et al. [Evaluation of the clinical efficacy of azithromycin in acute respiratory infections in children]. Clin Ter. 1994; 145: 35-39. Bottrill ID, Poe DS. Endoscope-assisted ear surgery. J Otol. 1995; 16: 158-163. Boulesteix J, Begue P, Dubreuil C, et al. Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate. Infection. 1995; 23 Suppl 2: S79-S82. Boulesteix J, Dubreuil C, Moutot M, Rezvani Y, Rosembaum M. Cefpodoxime proxetil five days versus cefixime eight days in the treatment of acute otitis media in children. Medecine Et Maladies Infectieuses. 1995; 25: 534-539. Bourgeois F, Lambert-Zechovsky N, Bingen E. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections]. Pathol Biol. 1993; 41: 555-561. Bowdler DA, Walsh RM. Comparison of the otoendoscopic and microscopic anatomy of the middle ear cleft in canal wall-up and canal wall-down.

Medications given to treat fungal or bacterial infections include penicillin, ampicillin, amoxicillin, cephalexin Keflex ; , cefuroxime Ceftin ; , cefprozil Cefzil ; , cefaclor Ceclor ; , cefixime Suprax ; , cefadroxil Duricef ; , erythromycin, clarithoromycin Biaxin ; , azithromycin Zithromax ; , nitrofurantoin Furaton, Macrobid ; , trimethoprim-sulphamethoxazole Septra, Bactrim, Cotrim ; , dicloxazcillin Dynapen ; , mupirocin Bactroban ; , ciprofloxacin Cipro ; , ofloxacin Floxin ; , tetracycline , doxycycline, metronidazole Flagyl ; , bacitracin, polymixin B, triple antibiotic ointment with bacitracin zinc neomycin sulfate polymyxin B sulfate Neosporin, Polysporin ; , fluconazole Diflucan ; , mycostatin Nystatin ; , clotrmazole Mycelex ; , and tolnaftate Tinactin ; . What do anti-fungal and anti-infectant medications do? These medications are used to treat fungal or bacterial infections. Some of these medications can be applied on the body surface while others may be taken by mouth. What should I tell the healthcare professional about the individual who will be taking these medications? Tell the healthcare professional about any alcohol or medications prescriptions, or nonprescription ; that the patient is taking. Tell if the individual is pregnant. Tell if the individual has liver or kidney disease. Tell about any antibiotics or antifungal medications recently taken and the effects or failures of these medications. Tell if the individual has an allergy to any medications or experienced a rash or difficulty breathing in the past after taking a medication. How should I give this medication and how should I store it? Give these medications by mouth unless indicated on the prescription. You can give these medications either with or without food unless indicated on the prescription. Give these medications on time and as prescribed. Store these medications at room temperature except for liquids, which may need refrigeration. Follow instructions on the prescription. Store AWAY from places with high moisture such as in bathrooms or over sinks. What side effects should I look for and when might I see them? The person taking the medication may have stomach distress, diarrhea, irritation where you apply topical medications, or the infection may get worse. Report immediately any skin rash, hives, or shortness of breath. page 16 and biaxin and Order cefixime online. Drug Name -Aabacavir 2 abacavir zidovudine lamivudine 2 ACCOLATE 2 ACCUTANE Oral ; 2 * acetaminophen butalbital 1 * * acetaminophen butalbital caffeine 1 * * acetaminophen butalbital caffeine codeine 1 * * acetaminophen codeine Liquid is Tier 2 ; 1 * * acetaminophen hydrocodone Liquid is Tier 2 ; 1 * * acetaminophen oxycodone 1 * * acetazolamide 500mg Sequels are Tier 2 ; 1 * * acetic acid 1 * * acetic acid aluminum acetate otic Generic equivalent of Domeboro Otic ; 1 * * acetic acid hydrocortisone liquid 1 * * acetic acid oxyquin ricin glycerin 1 * * acetylcysteine 1 * acitretin 2 ACTIMMUNE 2 ACTINEX 2 ACTONEL 2 ACTOS 2 * acyclovir 1 * acyclovir ointment 2 ADDERALL XR 2 ADVICOR 2 AEROBID, AEROBID-M 2 AGENERASE 2 * albuterol metered dose inhaler 1 * * albuterol nebulized 1 * * albuterol tablet & oral liquid 1 * alendronate 2 ALESSE 2 ALFERON-N 2 alglucerase 2 ALLEGRA Will become Tier 3 when OTC Claritin is available. ; 2 ALKERAN 2 * allopurinol 1 * almotriptan 2 ALOMIDE 2 ALORA 2 ALPHAGAN 2 ALTACE 2 altretamine 2 aluminum chloride 2 * amantadine 1 * AMERGE 2 AMICAR 2 * amiloride 1 * * amiloride hctz 1 * aminocaproic acid 2 aminoglutethimide 2 * aminophylline 1 * * amiodarone 1 * * ammonium lactate 1 * * amoxicillin 1 * * amoxicillin clavulanic acid Brand will become Tier 3 when generic is available. ; 1 * amphetamine dextroamphetamine 1 * amphetamine dextroamphetamine sr 2 * ampicillin 1 * amprenavir 2 ANA-KIT 2 anastrozole 2 ANCOBON 2 ANDRODERM 2 anthralin 2 apraclonidine 2 ARICEPT 2 ARIMIDEX 2 ARISTOCORT 2 artificial tear insert 2 4 Tier Drug Name ASACOL * aspirin butalbital caffeine * aspirin butalbital caffeine codeine * aspirin codeine * aspirin oxycodone * atenolol * atenolol chlorthalidone atorvastatin atovaquone * atropine ophthalmic ATROVENT AUGMENTIN Brand will become Tier 3 when generic is available. ; auranofin aurothioglucose AVANDIA AVC AVELOX AVONEX AXERT * azathioprine * azelaic acid azithromycin AZMACORT AZOPT -B * bacitracin ophthalmic * baclofen BACTROBAN beclomethasone nasal Including AQ ; beclomethasone oral inhaler BECLOVENT BECONASE Including AQ ; * belladonna phenobarbital benazepril benazepril amlodipine benazepril hctz BENZAMYCIN * benzocaine antipyrine liquid benzoyl peroxide erythromycin * benztropine * betamethasone dipropionate betamethasone dipropionate augmented * betamethasone valerate BETASERON betaxolol ophthalmic * bethanechol BETOPTIC, BETOPTIC-S BIAXIN Including XL ; bicalutamide BILTRICIDE bimatoprost * bisoprolol hctz brimonidine brinzolamide * bromocriptine budesonide inhalation suspension budesonide nasal Including AQ ; budesonide oral capsules budesonide inhaler * bumetanide busulfan butorphanol Max 3 cannisters 30 days ; -Ccabergoline calcipotriene * calcitonin injection calcitonin nasal * calcitriol capecitabine CAPITROL * captopril * captopril hctz * carbachol ophthalmic Tier Drug Name Tier 2 carbamazepine Including XR ; 2 1 * * carisoprodol 1 * 1 * CARMOL 40 2 1 * CARNITOR 2 1 * carvedilol 2 1 * CASODEX 2 1 * CEENU 2 cefdinir suspension 2 cefixime suspension 2 1 * cefprozil suspension 2 * cefuroxime 1 * CEFZIL SUSPENSION 2 1 CELLCEPT 2 * cephalexin 1 * 2 CEREDASE 2 CERUMENEX 2 cetirizine Will become Tier 3 when 2 OTC Claritin is available. ; 2 CHEMET 2 CHIBROXIN 2 1 * chlorambucil 2 1 * * chloramphenicol 1 * 2 * chlorhexidine 1 * 2 * chloroquine 1 * 2 * chlorothiazide 1 * chloroxine 2 1 * * chlorpheniramine phenyltolox pe pp 1 * chlorthalidone 1 * 2 * cholestyramine 1 * 2 * cholestyramine light 1 * 2 * choline mag salicylates 1 * 2 ciclopirox 2 CILOXIN 2 1 * * cimetidine 1 * 2 CIPRO 2 ciprofloxacin 2 ciprofloxacin ophthalmic 2 cisapride Limited access program by mfr; 1 * see : us.janssen for details ; 2 citric acid gluconic acid 2 1 * clarithromycin Including XL ; 2 1 * CLEOCIN 2 * clidinium chlordiazepoxide 1 * 1 * CLIMARA 2 * clindamycin 150mg ; 1 * 2 * clindamycin topical 1 * 1 * clindamycin vaginal gel 2 clofazimine 2 * clonazepam 1 * 2 * clonidine 1 * 2 * clonidine chlorthalidone 1 * 2 clopidogrel 2 1 * clotrimazole 2 clotrimazole vaginal suppository 1 2 * codeine 1 * 1 * * colchicine 1 * 2 COLESTID 2 colestipol 2 COMBIPATCH 2 COMBIVENT 2 1 * COMBIVIR 2 COMTAN 2 1 * CONCERTA 2 conjugated estrogens Includes vaginal cream ; 2 conjugated estrogens medroxyprogesterone 2 COPAXONE 2 1 * COREG 2 CORTENEMA 2 1 * CORTIFOAM 2 COSOPT 2 COUMADIN 2 1 * CRIXIVAN 2 1 * * cromolyn inhaled All forms are covered ; 1 * 1 * crotamiton 2 Drug Name Tier CUPRIMINE 2 cyanocobalamin nasal 2 CYCLESSA 2 * cyclobenzaprine 1 * * cyclopentolate 1 * cyclophosphamide 2 cycloserine 2 * cyclosporine microemulsion 1 * CYLERT 2 * cyproheptadine 1 * CYTADREN 2 CYTOMEL 2 CYTOTEC 2 CYTOVENE 2 CYTOXAN 2 -Ddalteparin 2 * danazol 1 * DANTRIUM 2 dantrolene 2 DAPSONE 2 DARANIDE 2 DARAPRIM 2 DDAVP TABLET 2 delavirdine 2 demecarium 2 DEMSER 2 DEMULEN 2 DENAVIR 2 DEPAKENE 2 DEPAKOTE 2 * desmopressin nasal 1 * desmopressin tablet 2 * desonide 1 * * desoximetasone 1 * DETROL Incl LA ; 2 * dexamethasone 1 * * dexamethasone ophthalmic Maxidex is Tier 2 ; 1 * * dextroamphetamine Including SR ; 1 * * diabetic blood testing strips * * diabetic urine testing products * DIASTAT 2 diazepam rectal 2 DIBENZYLINE 2 dichlorphenamide 2 * diclofenac 1 * * diclofenac ophthalmic 1 * * dicloxacillin Liquid is Tier 2 ; 1 * * dicyclomine 1 * didanosine 2 DIDRONEL 2 dienestrol vaginal cream 2 DIFLUCAN 2 DIFLUCAN VC 2 * diflunisal 1 * digoxin 0.5mg not covered ; 2 dihydroergotamine Max 8 amps 30 days ; 2 DILANTIN 2 * diltiazem All generics are Tier 1 ; 1 * DIOVAN 2 DIOVAN HCT 2 * diphenoxylate atropine 1 * * dipivefrin ophthalmic 1 * DIPROLENE 2 DIPROLENE AF 2 * dipyridamole 1 * * disopyramide Including CR ; 1 * * disulfiram 1 * divalproex 2 donepezil 2 DOPAR 2 dornase alfa 2 dorzolamide 2 dorzolamide timolol 2.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The New York Eye and Ear Infirmary, Ophthalmology Times, Eyetech Pharmaceuticals, Inc, or Pfizer Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings and lincocin. Validated Simultaneous Estimation of Ornidazole and Cefixime by RP-HPLC in Pure and Pharmaceutical Dosage Form N. Sreekanth, K. Shivshanker, N. Harikrishnan, C. Roosewelt, G. Srinivasa Rao and V. Gunasekaran Asian J. Chem., Vol. 19, pp. 4297-4302 2007 ; Validated Simultaneous Estimation of Simvastatin and Ezetimibe by RP-HPLC in Pure and Pharmaceutical Dosage Form K. Shivshanker, N. Sreekanth, N. Harikrishnan, C. Roosewelt, G. Srinivasa Rao and V. Gunasekaran Asian J. Chem., Vol. 19, pp. 4303-4308 2007 ; Characterization and Calculation of Detonation Parameters of 2, 6-Diamino-3, 5-dinitropyrazine-1oxide by BKW Codes Farideh Gouranlou and Iraj Kohsari Asian J. Chem., Vol. 19, pp. 4309-4314 2007 ; Hepatoprotective Activity of Leaves of Sapindus trifoliatus Linn. Jennifer Pinto, Ishwar Bhat, F. Ronald, E.V.S. Subramanyam and D.S. Sathyanarayana Asian J. Chem., Vol. 19, pp. 4315-4322 2007 ; Nutritional and Zinc Levels in Serum and Hair of University Students in Nigde, Turkey Zeynep Alan ztrk, Rifat Battaloglu, Kadriye Kayakirilmaz, Meral Aksoy and Emel Bayol Asian J. Chem., Vol. 19, pp. 4323-4332 2007 ; Chemical Compositions of the Essential Oils of Different Stages of the Growth of Stachys inflata Benth. from Iran Mohammad Hadi Meshkatalsadat, Marzieh Piraei and Hamzeh Amiri Asian J. Chem., Vol. 19, pp. 4333-4336 2007 ; Chemical Constituents of the Essential Oils from Flower, Leave and Stem of the Salvia brachycalyx Boiss. from Iran Mohammad Hadi Meshkatalsadat and Mahbobeh Asadi Asian J. Chem., Vol. 19, pp. 4337-4340 2007 ; Determination of the Rate of Litter Decomposition and Dynamic of Carbon, Nitrogen and Phosphorus of Fagus orientalis in Asalem and Vaz Regions Vahid Hosseini and Pirouz Azizi Asian J. Chem., Vol. 19, pp. 4341-4346 2007 ; Ammonia Volatilization from Different Soils Amended with Organic Materials Akbar Forghani Asian J. Chem., Vol. 19, pp. 4347-4352 2007 ; Electrical and Optical Characterization of Thermally Evaporated Titanyl Phthalocyanine Thin Films Joseph Sebastian and C.S. Menon Asian J. Chem., Vol. 19, pp. 4353-4362 2007 ; Synthesis and Antimicorbial Studies of Some Azetidinone Derivatives from 8-Hydroxy Quinoline K. Ishwar Bhat, Supriya Maity and E.V.S. Subrahmanyam Asian J. Chem., Vol. 19, pp. 4363-4367 2007.

Long-Term eU TransiTion sTraTegy for cUBa The EU should prepare a long-term strategy for the transition in Cuba. After Fidel Castro has gone, European countries must be ready to actively help in the first steps of the Cuban transition towards democracy. EU policies should use all possible contacts to prepare Cuban society to the maximum possible extent for a swift and peaceful transition to a democratic political system and market economy. An advisory group should be formed by the EU which UnconDiTional release of would provide technical assistance PoliTical Prisoners to the future Cuban democratic govThe EU should call for the unconditional ernment. New member states` experelease of all political prisoners. Prison- rience with the transition to democers released over the last two years were racy could be help significantly in released only conditionally and, since this process. their release, have been threatened with their prison sentences being resume if free floW of informaTion they continue with their activities. All possible means should be employed to facilitate the free flow of informainTroDUcTion of Time frames tion to Cuba. The diplomatic missions anD Benchmarks of EU Member States should serve as As it increasingly obvious that current an accessible source of information EU policy has not led to any improve- for all Cuban citizens. Every mission ments regarding the transition to democ- of an EU Member State should be racy or the human rights situation on encouraged to have at least one comthe island, it would be recommended puter with Internet connection accesto strengthen the position's appeal on sible for the Cuban general public. It human rights, introducing realistic time should also make available a selection frames and measurable benchmarks for of European newspapers, magazines improvement. These should be comple- and recently published books. At least mented by targeted punitive measures. some of these publications should be available in Spanish. PUniTiVe measUres TargeTeD aT The cUBan leaDershiP All available means should be used Punitive measures should, in particu- to enable Cuban students to receive lar, be considered regarding the top scholarships to study at European uniechelons of the Cuban government. versities. Scholarships for young peoHOMs in Havana should prepare a list ple who want to participate in "disof Cuban officials who are directly tance learning" in degree programs responsible for human rights violations. abroad and the exchange of young This list should be regularly updated, professionals should also be estabmade public and distributed in Cuba. In lished. European radio stations with response to the expulsions of EU politi- worldwide coverage should also be cians and other visitors to Cuba, the EU supported to broadcast more inforshould reciprocate by applying a visa mation on Cuba in their Spanish lanban to selected Cuban officials. guage programs.

1. Treat for gonococcal infection Cefixime 400mg single oral dose 2. Treat for chlamydia infection Azithromycin 1 g single oral dose Reassure patient and educate Provide analgesics, if necessary Promote and provide condoms Offer HIV Counseling and Testing. These quality control limits apply only to tests conducted with H. influenzae ATCC 49247 using Haemophilus Test Medium HTM ; .2 These quality control limits apply only to tests conducted with S. pneumoniae ATCC 49619 using Mueller-Hinton agar supplemented with 5% sheep blood incubated in 5% CO2. Table 1 . Percentage ofViable J774 Cells after Treatment with CFX in the Presence or Absence of GFZ and buy flagyl. Not expected to be irritating in the EEC OECD 4 hour semi-occluded as opposed to this 24 hour occluded. No additional effects were reported. : A single 24-hour application of the test material to intact, occluded rabbit skin was mildly irritating. The test material is not expected to be irritating when applied to intact skin in the EEC OECD 4-hour semi-occluded test. Irritation Scores Mean Scores: 24hr. MODERATE--nausea, salivation, lacrimation, abdominal cramps. vomiting, sweating, slow pulse, muscular tremores. SEVERE-diarrhoea. pinpoint and non-reactive puplis, respiratory difficulty, pulmonary edema, cyanosis, loss of sphincter control convulsions. coma and heart block.
The advantage of cefixime is that it can be administered orally!